Daniel Barber
CEO, President at Aquestive Therapeutics, Inc. (AQST)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.2M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 16SEC | AQSTAquestive Therapeutics, Inc. | Sell Plan | 25,000652,317 held (−4%) | $4.82 | $120K | -0.8% |
| Aug 18SEC | AQSTAquestive Therapeutics, Inc. | Sell Plan | 25,000585,574 held (−4%) | $4.29 | $107K | +11.4% |
| Jul 17SEC | AQSTAquestive Therapeutics, Inc. | Sell Plan | 4,631630,943 held (−1%) | $4.03 | $19K | +18.6% |
| Jul 17SEC | AQSTAquestive Therapeutics, Inc. | Sell Plan | 20,369610,574 held (−3%) | $4.00 | $81K | +19.5% |
| Jun 16SEC | AQSTAquestive Therapeutics, Inc. | Sell Plan | 25,000635,574 held (−4%) | $4.16 | $104K | +14.9% |
| May 18SEC | AQSTAquestive Therapeutics, Inc. | Sell Plan | 8,257660,574 held (−1%) | $4.29 | $35K | +11.4% |
| Mar 11SEC | AQSTAquestive Therapeutics, Inc. | Sell | 180,6771,004,753 held (−15%) | $4.17 | $753K | +14.6% |
- Sell
CEO, President Daniel Barber sold $120K of AQST at $4.82 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Daniel Barber sold $107K of AQST at $4.29 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Daniel Barber sold $19K of AQST at $4.03 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Daniel Barber sold $81K of AQST at $4.00 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Daniel Barber sold $104K of AQST at $4.16 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Daniel Barber sold $35K of AQST at $4.29 — pre-scheduled 10b5-1 plan sale.